fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 30 Aug 2026

GROWW, full dossier

Zerodha's broking revenue fell 10.4% from ₹3,066 Cr in FY25 to ₹2,738 Cr in FY26, and net transaction charges fell to zero from ₹400 Cr in FY25 due to SEBI's true-to-label norm framework.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Zerodha's broking revenue fell 10.4% from ₹3,066 Cr in FY25 to ₹2,738 Cr in FY26, and net transaction charges fell to zero from ₹400 Cr in FY25 due to SEBI's true-to-label norm framework.

inc42.com30 Aug 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Billionbrains Garage Ventures

₹180.11

▼ -2.07%

Close (EOD), as of 1 Oct 2026 · source

Billionbrains Garage Ventures: results, dividends, orders, the full cited record →

More on Billionbrains Garage Ventures

Investment platform Groww has rolled out access to US-listed stocks and exchange-traded funds to select customers.

29 Sep 2026 · 1 publisher

Discount brokerage firms including Groww, Zerodha, Angel One, Upstox and others have approached the Securities and Exchange Board of India (SEBI) seeking changes to the proposed framework for merchant discount rate (MDR) on UPI transactions.

18 Sep 2026 · 1 publisher

Groww shares fell nearly 4% on 16 September amid a block deal involving the transfer of 10.07 crore shares at a floor price of ₹ 191.45.

16 Sep 2026 · 1 publisher

Groww added 2.23 lakh active clients in August, accounting for 44% of the 5.12 lakh net active clients added by India's broking industry during the month.

9 Sep 2026 · 2 publishers

Groww added 2.23 lakh active clients in August, increasing its market share from 28.88% to 29.04%.

8 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.